Jakob Liermann

1.2k total citations
55 papers, 789 citations indexed

About

Jakob Liermann is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, Jakob Liermann has authored 55 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 22 papers in Radiation. Recurrent topics in Jakob Liermann's work include Advanced Radiotherapy Techniques (22 papers), Radiation Therapy and Dosimetry (17 papers) and Peptidase Inhibition and Analysis (11 papers). Jakob Liermann is often cited by papers focused on Advanced Radiotherapy Techniques (22 papers), Radiation Therapy and Dosimetry (17 papers) and Peptidase Inhibition and Analysis (11 papers). Jakob Liermann collaborates with scholars based in Germany, United States and Italy. Jakob Liermann's co-authors include Jürgen Debus, Patrick Naumann, Stefan A. Koerber, Klaus Herfarth, Mustafa Syed, Uwe Haberkorn, Frederik L. Giesel, Sebastian Adeberg, Fabian Staudinger and Manuel Röhrich and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Jakob Liermann

50 papers receiving 781 citations

Peers

Jakob Liermann
Mustafa Syed Germany
Weixu Hu China
Woong‐Ki Chung South Korea
Priya Jayachandran United States
A. Fernandes United States
Dennis Vriens Netherlands
Jakob Liermann
Citations per year, relative to Jakob Liermann Jakob Liermann (= 1×) peers Eric Tonndorf‐Martini

Countries citing papers authored by Jakob Liermann

Since Specialization
Citations

This map shows the geographic impact of Jakob Liermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakob Liermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakob Liermann more than expected).

Fields of papers citing papers by Jakob Liermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakob Liermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakob Liermann. The network helps show where Jakob Liermann may publish in the future.

Co-authorship network of co-authors of Jakob Liermann

This figure shows the co-authorship network connecting the top 25 collaborators of Jakob Liermann. A scholar is included among the top collaborators of Jakob Liermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakob Liermann. Jakob Liermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weykamp, Fabian, Katharina Seidensaal, Christoph Springfeld, et al.. (2025). Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancer. Radiation Oncology. 20(1). 23–23. 1 indexed citations
2.
Lau, Harold, Fabian Weykamp, Sebastian Regnery, et al.. (2025). Prospective planning comparison of magnetic resonance-guided vs. internal target volume-based stereotactic body radiotherapy of hepatic metastases – Which patients do really benefit from an MR-linac?. Clinical and Translational Radiation Oncology. 52. 100941–100941.
3.
Chang, De‐Hua, Philipp Mayer, Jakob Liermann, et al.. (2025). Longitudinal CE-MRI-based Siamese network with machine learning to predict tumor response in HCC after DEB-TACE. Cancer Imaging. 25(1). 104–104.
5.
Tessonnier, Thomas, Ivana Đokić, Stephan Brons, et al.. (2024). Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro. Cancers. 16(8). 1497–1497. 1 indexed citations
6.
Bauer, Julia, M. Ellerbrock, T. Hansmann, et al.. (2024). TOWARDS DAILY ONLINE MR-IMAGE-GUIDED PARTICLE THERAPY: FIRST CLINICAL APPLICATION OF A SHUTTLE-BASED WORKFLOW AT THE HEIDELBERG ION-BEAM THERAPY CENTER. International Journal of Particle Therapy. 12. 100243–100243. 1 indexed citations
7.
Baumann, Lukas, Jakob Liermann, Philipp Hoegen, et al.. (2024). Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer. Frontiers in Oncology. 14. 6 indexed citations
8.
Seidensaal, Katharina, Burkhard Lehner, Jakob Liermann, et al.. (2024). Hypofractionated proton and carbon ion beam radiotherapy for sacrococcygeal chordoma (ISAC): An open label, randomized, stratified, phase II trial. Radiotherapy and Oncology. 198. 110418–110418. 5 indexed citations
9.
Meixner, Eva, Sebastian Klüter, Semi Harrabi, et al.. (2024). Validation of different automated segmentation models for target volume contouring in postoperative radiotherapy for breast cancer and regional nodal irradiation. Clinical and Translational Radiation Oncology. 49. 100855–100855. 1 indexed citations
10.
Olkus, Alexander, Aurelie Tomczak, Anne Berger, et al.. (2024). Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data. Targeted Oncology. 19(2). 213–221. 9 indexed citations
11.
Liermann, Jakob, Arndt‐Christian Müller, Daniel Zips, et al.. (2023). Pelvic Irradiation for Node-Positive Prostate Cancer After Prostatectomy: Long-Term Results of the Prospective PLATIN-4 and PLATIN-5 Trials. International Journal of Radiation Oncology*Biology*Physics. 118(4). 1011–1017. 5 indexed citations
13.
Christensen, Jeppe Brage, A. Runz, Jakob Liermann, et al.. (2023). A phantom to simulate organ motion and its effect on dose distribution in carbon ion therapy for pancreatic cancer. Physics in Medicine and Biology. 68(24). 245013–245013. 6 indexed citations
14.
Koerber, Stefan A., Manuel Röhrich, Jakob Liermann, et al.. (2023). Impact of68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers. Journal of Nuclear Medicine. 64(11). 1712–1720. 23 indexed citations
15.
Hielscher, Thomas, Matthias Lang, Thomas Pausch, et al.. (2023). Comparison of early and late 68Ga-FAPI-46-PET in 33 patients with possible recurrence of pancreatic ductal adenocarcinomas. Scientific Reports. 13(1). 17848–17848. 7 indexed citations
16.
Hoegen, Philipp, Sebastian Regnery, Fabian Weykamp, et al.. (2022). Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk. Clinical and Translational Radiation Oncology. 39. 100567–100567. 11 indexed citations
17.
Liermann, Jakob, Marc Münter, Patrick Naumann, et al.. (2022). Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial. Clinical and Translational Radiation Oncology. 34. 15–22. 8 indexed citations
18.
Röhrich, Manuel, Mustafa Syed, Frederik L. Giesel, et al.. (2021). 68Ga-FAPI-PET/CT improves diagnostic staging and radiotherapy planning of adenoid cystic carcinomas – Imaging analysis and histological validation. Radiotherapy and Oncology. 160. 192–201. 42 indexed citations
19.
Held, Thomas, Paul Windisch, Sati Akbaba, et al.. (2019). Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions. Radiation Oncology. 14(1). 202–202. 5 indexed citations
20.
Liermann, Jakob, Mustafa Syed, Thomas Held, et al.. (2018). Advanced Radiation Techniques in the Treatment of Esthesioneuroblastoma: A 7-Year Single-Institution’s Clinical Experience. Cancers. 10(11). 457–457. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026